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Abstract
Background: Due to the growing prevalence of type 2 diabetes, new dietary solutions are needed to help improve glucose and
lipid metabolism in persons at high risk of developing the disease. Herein we investigated the effects of low-insulin-response grain
products, fatty fish, and berries on glucose metabolism and plasma lipidomic profiles in persons with impaired glucose metabolism.
Methodology/Principal Findings: A l t o g e t h e r1 0 6m e na n dw o m e nw i t hi m p a i r e d glucose metabolism and with at least two
other features of the metabolic syndrome were included in a 12-week parallel dietary intervention. The participants were
randomized into three diet intervention groups: (1) whole grain and low postprandial insulin response grain products, fatty fish
three times a week, and bilberries three portions per day (HealthyDiet group), (2) Whole grain enriched diet (WGED) group, which
includes principally the same grain products as group (1), but with no change in fish or berry consumption, and (3) refined wheat
breads (Control). Oral glucose tolerance, plasma fatty acids and lipidomic profiles were measured before and after the intervention.
Self-reported compliance with the diets was good and the body weight remained constant. Within the HealthyDiet group two hour
glucose concentration and area-under-the-curve for glucose decreased and plasma proportion of (n-3) long-chain PUFAs increased
(False Discovery Rate p-values ,0.05). Increases in eicosapentaenoic acid and docosahexaenoic acid associated curvilinearly with
the improved insulin secretion and glucose disposal. Among the 364 characterized lipids, 25 changed significantly in the
HealthyDiet group, including multiple triglycerides incorporating the long chain (n-3) PUFA.
Conclusions/Significance: The results suggest that the diet rich in whole grain and low insulin response grain products,
bilberries, and fatty fish improve glucose metabolism and alter the lipidomic profile. Therefore, such a diet may have a
beneficial effect in the efforts to prevent type 2 diabetes in high risk persons.
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Introduction
The beneficial health effects related to consumption of whole
grain [1–3], fish or fish oil supplements [4,5] and polyphenol rich
foods such as berries [6] are well documented. However, the
synergistic effects of these foods on lipid and glucose metabolism in
persons at risk for type 2 diabetes have not yet been investigated.
In epidemiological studies the intake of whole grain has been
associated with lower risk of obesity, insulin resistance, elevated
fasting glucose and the incidence of diabetes [7]. Rye bread
induces post-prandially lower insulin response than wheat
independently of the fiber content [8–10]. Additionally, a
twelve-week consumption of low insulin response diet (rye bread
and pasta) has been shown to enhance early insulin secretion in
persons with metabolic syndrome [2]. This diet also modulated
gene expression profile of abdominal subcutaneous tissue by
down-regulating genes involved in insulin signaling and apoptosis
[11]. However, while the rye bread and pasta diet did not alter the
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wheat bread and potato) led to increased concentrations of
proinflammatory lysophosphatidylcholines (LPCs) [12]. This
suggests that even a moderate dietary carbohydrate modification
may affect the lipid metabolism.
Bilberries are particularly abundant in polyphenols, especially
anthocyanins [13]. Growing evidence from animal studies suggests
that polyphenols as well as foods and beverages rich in polyphenols
may positively influence carbohydrate metabolism by attenuating
postprandial glycemic responses and fasting hyperglycemia as well
as by improving acute insulin secretion and insulin sensitivity [6].
Human intervention studies using berries or anthocyanin extracts
have also demonstrated significant improvements in low density
lipoprotein (LDL) oxidation, lipid peroxidation, total plasma
antioxidant capacity and dyslipidemia [14].
Epidemiological studies have demonstrated associations be-
tween the (n-3) long-chain polyunsaturated fatty acids (PUFA),
found mainly in fish, and lower prevalence of insulin resistance
and type 2 diabetes [15]. However, clinical trials on (n-3) PUFA-
enriched diets have so far led to conflicting results [15–18]. The
mechanisms behind the potential beneficial effect of (n-3) PUFA
on glucose metabolism are poorly understood. The evidence so far
points to the role of insulin receptor signaling [19], inflammation
[20,21], cell membrane fatty acid composition [22,23], circulating
hormones and adipocytokines [18] or G protein-coupled receptor
120 [24]. By applying a lipidomics approach we have recently
shown that an eight-week consumption of fatty fish four to five
times per week led to decreased plasma concentrations of potential
mediators of lipid-induced insulin resistance and inflammation,
including ceramides, diacylglycerols and LPCs [25]. Lipids are
known to play a central role in the progression of glucose
metabolism towards diabetes [26]. The emergence of lipidomics
has enabled the global study of lipids in cells, tissues and biofluids,
and revitalized the study of lipids in the context of nutrition
research and clinical biomarker discovery [27].
Herein we investigate the effects of whole grain and low insulin
response grain products, fatty fish, and bilberries on glucose
metabolism and plasma lipidomic profile in individuals with the
impaired fasting glucose (IFG) or impaired glucose tolerance (IGT)
and features of metabolic syndrome. We also aimed to study
whether the increase in plasma eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) content is related to the improved
glucose metabolism.
Materials and Methods
The protocol for this trial and supporting CONSOT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Participants and study design
Participants volunteered to the study and gave their written
informed consent. The study plan was approved by the Research
Ethics Committee, Hospital District of Northern Savo. The
intervention was performed in accordance of Helsinki Declaration.
Altogether 131 participants were recruited for a 12-week
parallel controlled dietary intervention study from Kuopio area
(Figure 1). The inclusion criteria were age 40–70 years, impaired
glucose metabolism (fP-gluc 5.6–6.9 mmol/l (IFG) or in oral
glucose tolerance test (OGTT) 2 hour P-gluc 7.8–11.0 mmol/l
(IGT)) and at least two of the following: BMI 26–39 kg/m
2, waist
circumference $102 cm in men and $88 cm in women, serum
triglycerides $1.7 mmol/l, HDL,1.0 mmol/l in men and
,1.3 mmol/l in women or blood pressure $130/$85 mmHg
or use of medication for hypertension. The cut-off values were
based on NCEP Adult Treatment Panel III, 2001. The
participants were enrolled in the study sequentially. Of all
participants, 86% had at least one medication. In the HealthyDiet
group, 5.4% of the participants did not have any medication. The
respective proportions were 14.7% and 22.9% in the whole grain
enriched diet (WGED) group and Control group (x
2-test, p=0.1).
Most commonly used medications were statins (27%), angiotensin
II inhibitors (27%), beta blockers (23%), calcium antagonists
(20%), anticoagulants (17%) and ACE inhibitors (15%). None of
the subjects used glucose lowering drugs and uses of statins, beta
blockers or diuretics, and hormonal replacement therapy were
very similar between the groups (Table 1). Besides some minor
exceptions, participants continued their medications unchanged
throughout the study.
The participants were randomly assigned by the study nurse to
one of the following groups: HealthyDiet, WGED or Control.
Randomization was performed by matching according to gender
and medians of age, BMI and fasting plasma glucose of the study
population at screening. The matching produced equal amounts of
the certain strata classes among the groups. Altogether 106
participants completed the study. Majority of the drop-outs did not
state the reason for drop-out. The reported reasons were busy at
work, difficulty to follow the diet instructions, bad experience of
biopsy and other physical or personal reasons. Drop-outs were
significantly younger than completers (mean age was 5568 vs.
5967), but otherwise did not differ based on their clinical
characteristics.
In the HealthyDiet group (n=37) the participants replaced their
habitually used cereal products with breads having a low
postprandial glucose and insulin response, contributing up to
20–25% of total energy intake (40% share of endosperm rye
bread, 10% share of sourdough whole meal wheat bread, and 50%
share of a selection of commercial rye breads). The recommended
intake of whole meal pasta was at least 3.5 deciliter (uncooked) a
week. The fiber content (g/100 g) of the study cereal products was:
endosperm rye bread 6.9, whole meal wheat bread 6.4,
commercial rye breads 10–14.4 and pasta 6. Besides the above
mentioned cereal products, one portion of their habitually used
cereal product was allowed to be eaten daily, e.g. porridge, cereals
or pastries. Participants were also instructed to eat fatty fish meals
(100–150 g of fish/meal) three times a week. The following fish
species were recommended: salmon, rainbow trout, bream, Baltic
herring, roach, vendace, white fish, char, trout, red-fish, mackerel
and anchovy. In fish preparation, participants were advised to
avoid sources of saturated fat, such as butter and cream. Bilberries
were eaten 3 portions per day. Bilberries were served as frozen,
puree and dried powder. The total amount of three portions is
equivalent to 300 grams of fresh bilberries. Habitual use of other
berries was allowed with a max 3–4 portion a week.
In the WGED group (n=34), the participants consumed the
same cereal products as in the HealthyDiet group. Additionally,
they were given whole grain oat biscuits that they were allowed to
consume one portion per day on a voluntary basis. Biscuits
contained 8–8.5 g/100 g of dietary fiber and 16–18 g/100 g of
fat, of which 4.3–7.7 g was saturated. Participants in the WGED
group were asked not to change their fish and berry consumption.
In the Control group (n=35) participants replaced their
habitually used breads with refined wheat breads (dietary fiber
3–4.3 g/100 g) and other cereal products, e.g. porridge or pasta,
with low fiber products (,6 g/100 g dietary fiber). Participants
were allowed to eat maximum of 1–2 portions of rye products per
day. The intake of bilberries was not allowed and other berries
were allowed maximum of 3–4 times per week with maximum of 1
Effects of Diet on Glucose and Lipid Metabolism
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e22646deciliter at a time. Fish was allowed to be eaten no more than once
a week. Otherwise, the habitual diet and living habits were kept
unchanged in all groups.
Participants recorded daily the use of the test breads (all groups),
pasta (HealthyDiet and WGED), oat biscuits (WGED), bilberries
(HealthyDiet), and fish (HealthyDiet). Four-day food records
Figure 1. Flow diagram of the study.
doi:10.1371/journal.pone.0022646.g001
Table 1. Baseline characteristics of the participants.
1,2
HealthyDiet n=37 WGED
3 n=34 Control n=35
Gender, male/female 17/20 17/17 18/17
Age, years 58675 8 685 9 67
Body weight, kg 89.8612.2 89.2615.3 89.7613.0
Body mass index, kg/m
2 31.163.6 31.463.4 31.063.6
Waist circumference, cm 105.669.5 106.3611.1 105.8610.0
Serum cholesterol, mmol/l 5.160.9 5.161.0 5.461.0
LDL cholesterol, mmol/l 3.160.7 3.260.8 3.460.8
HDL cholesterol, mmol/l 1.360.3 1.260.4 1.360.3
Serum triacylglycerols, mmol/l 1.660.6 1.560.8 1.560.8
Fasting plasma glucose, mmol/l 6.160.5 6.160.4 6.260.5
Plasma glucose OGTT 2 hour, mmol/l 6.761.7 6.661.6 6.861.9
Systolic blood pressure, mmHg 137613 135616 139612
Diastolic blood pressure, mmHg 89678 6 688 8 67
How many of the MetS characteristics fulfilled:
4
2 characteristics, % 11 15 14
3 characteristics, % 43 38 43
4 characteristics, % 24 29 29
5 characteristics, % 22 18 14
Use of statins, n 10 10 9
Use of hormonal replacement therapy, n 34 3
Use of beta blocker or diuretics, n 11 12 9
1Values are mean 6 SD,
2There were no significant differences in clinical characteristics between the groups at baseline,
3Whole grain enriched diet,
4On top of the impaired fasting glucose or glucose tolerance.
doi:10.1371/journal.pone.0022646.t001
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study persons during the run-in period and three times during the
intervention period in all groups.
Two-hour oral-glucose-tolerance test
OGTT was performed at baseline and after the 12-week
intervention. After the fasting blood sample was drawn, the
participants drank a glucose solution (75 g glucose/3 dl) within
3 min. Blood samples were drawn through the catheter 30, 60,
120 min after the beginning of the glucose solute ingestion for the
measurement of plasma glucose and insulin concentrations. The
glucose and insulin areas under the curve (AUCs) were calculated.
Disposition index (DI) is a product of measures of insulin
sensitivity and first-phase insulin secretion which is predictive of
conversion to diabetes [28,29]. Insulinogenic index (IGI) and
quantitative insulin sensitivity check index (QUICKI) were
calculated as following: IGI=(insulin 30 min 2 insulin 0 min,
pmol/L)/(glucose 30 min 2 glucose 0 min, mmol/L), and
QUICKI=1/(lg10(insulin 0 min, mU/L)+lg10(glucose 0 min,
mg/dl)). Disposition index was calculated as a product of IGI
and QUICKI. Homeostasis model of insulin resistance (HOMA-
IR) was calculated as following: (fasting glucose mmol/l6fasting
insulin mU/L)/22.5.
Biochemical analyses
Concentrations of serum total, LDL and HDL cholesterol and
triglycerides were analyzed using commercial kits (981813,
981656, 981823 and 981786, respectively, Thermo Electron
Corporation, Vantaa, Finland) and Thermo Fisher Konelab
20XTi Analyzer (Thermo Electron Corporation, Vantaa, Fin-
land). Plasma insulin concentration was analyzed with a
chemiluminescent immunoassay (Advia Centaur Immunoassay
System, Siemens Medical Solution Diagnostics,Tarrytown, NY,
USA). Plasma glucose was analyzed by using Konelab 20XTi
Clinical Chemistry Analyzer and Enzymatic photometric (glucose
hexokinase) method (Konelab System Reagents, Thermo Fisher
Scientific, Vantaa, Finland).
Fatty acids
Fasting blood samples for fatty acids and lipidomics analyses
were taken before and after the intervention. Both samples were
available from 105 participants (HealthyDiet group n=37,
WGED group n=34, Control group n=34). Lipids from plasma
samples (50 ml) were extracted by a mixture of chloroform and
methanol (2:1, 400 ml) after addition of 40 ml NaCl 0.9% (0.15 M)
and 10 ml internal standard (heptadecantrienoate TG C17:0
1659.24 mg/l+FFA C17:0 584.1 mg/l). The mixture was vortex-
ed 1 min and incubated 30 min at room temperature. The lower
layer was separated (centrifuged 10 000 rpm 5 min) and evapo-
rated into dryness under nitrogen flow.
The residue was dissolved into petroleumether (700 ml, boiling
point 40–60u C) and vortexed. Bound fatty acids were trans-
methylated with NaOME (250 ml, sodium methoxide in dry
methanol 0.5 M) by vortexing and boiling at 45u C for 5 minutes.
The mixture was acidified by adding 15% solution of NaHSO4
(500 ml) and evaporated petroleumether was substituted by adding
200 ml of it (vortexed). The mixture was transferred into
microtubes (glass tubes washed with 200 ml of petroleum ether)
and centrifuged 10 000 rpm, 5 min. The petroleumether layer
containing FAME and FFA was separated into a GC vial,
evaporated under nitrogen flow and redissolved into hexane
(500 ml) and vortexed.
1 ml aliquots were used for GC injection at 260u C (splitless).
The Agilent 7890 Gas Chromatography equipped with HP-FFAP
Polyethylene Glycol TP column (25 m6200 mm60.3 mm) was
used. H2 was used as carrier gas at a total flow of 44.5 ml/min.
The initial oven temperature was 70u C for 1.5 min and the
temperature was increased at rate of 15u C/min until 240u C. The
fatty acids were detected by flame ionization detector at 300u C.
Lipidomics
Plasma samples (10 ml) were diluted with 10 ml sodium chloride
(0,9%) and 20 ml of an internal standard mixture containing 10
lipid classes and 100 ml chloroform/methanol (2:1) were added.
The mixture was homogenised by vortexing 2 minutes and the
extraction time was around 40 minutes at room temperature.
After centrifugation (10000 RPM, 3 minutes), an exact aliquot
(60 ml) of the lower layer was transferred into an HPLC vial insert
and 10 ml an external standard mixture containing 3 labelled
standards was added to the lipid extract. The sample order for
LC/MS analysis was randomised.
Lipid extracts were analyzed on a Waters Q-Tof Premier mass
spectrometer combined with ultra performance liquid chromatog-
raphy (UPLC). The column was an Acquity UPLC
TM BEH C18
2.16100 mm with 1.7 mm particles. Column temperature was
kept at 50uC and the temperature of the sample organizer was set
at 10uC. The binary solvent system consisted of A. water (1% 1M
NH4Ac, 0.1% HCOOH) and B. LC-MS grade isopropanol:ace-
tonitrile (1:1, 1% 1M NH4Ac, 0.1% HCOOH). The gradient
started from 65% A/35% B and reached 80% B in 2 min, 100% B
in 7 minutes and remained at this level for next 7 minutes. The
total run time including a 4 min re-equilibration step was 18 min.
The flow rate was 400 ml/min and the injection volume 2.0 ml.
The data was collected in centroid form by using electro spray
ionization + mode at mass range of m/z 300–1200 and with scan
duration of 0.2 sec. The voltages of the sampling cone and
capillary were 40.0 V and 3.0 kV, respectively. The source
temperature was set at 120uC and nitrogen was used as
desolvation gas (795 L/h) at 270uC. Reserpine (200 mg/L) was
the lock spray reference compound at a flow rate of 8 ml/min and
the scan was done at 10 s frequency.
The data was processed by using MZmine 2 software [30] and
the lipid identification was based on an internal spectral library.
The MZmine 2 data processing included chromatogram building,
peak deconvolution, deisotoping, alignment, filtering and gap
filling. The quality of data was first estimated by checking the shifts
in retention times and peaks in the blank control samples. There
were the maximum of 0.02 minute shifts in the retention times of
standard compounds and only a few peaks were documented in
the blanks.
Lipids were identified by comparing with an internal spectral
library including MS and MS/MS data. All monoacyl lipids
except cholesteryl esters, such as monoacylglycerols and mono-
acyl-glycerophospholipids, were normalized with PC(17:0/0:0), all
diacyl lipids except ethanolamine phospholipids with PC(17:0/
17:0), all ceramides with Cer(d18:1/17:0), all ethanolamine
phospholipids with PE(17:0/17:0), and all TG and cholesteryl
esters with TG(17:0/17:0/17:0). Unidentified lipids were calibrat-
ed with PC(17:0/0:0) for retention times less than 300 seconds,
with PC(17:0/17:0) for retention times between 300 and
410 seconds, and with TG(17:0/17:0/17:0) for higher retention
times. Identifications and exact fatty acid compositions of all of the
most interesting lipids were confirmed with MS/MS analyses.
Statistical analyses
The primary aim of this study was to see changes in glucose
metabolism. Power calculations were based on fasting glucose. By
using test significance a-level 0.05, 80% power and aim to see 5%
Effects of Diet on Glucose and Lipid Metabolism
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e22646Effects of Diet on Glucose and Lipid Metabolism
PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e22646difference between the groups the appropriate sample size was
37/group. Statistical analyses were performed using the SPSS
statistical software (version 14.0, SPSS Inc., Chicago, IL) and R
Project for Statistical Computing version 2.7.2 [31] and nlme R-
package version 3.1–96 [32]. The normality of the distributions
of the variables was estimated based on histograms. Linear
mixed-effect models were used to analyze group differences in the
baseline and during the intervention. Quantitative dependent
variables were transformed to base-10 logarithmic scale to
account for non-normal distributions. Selected confounding
phenotypes were included in the models as covariates (age,
gender, BMI, insulin and glucose), and participant’s identifiers
were included as a grouping random effect. Interaction term
between group and intervention time-point (before or after
intervention) was used to examine group related changes during
the intervention. The Control group was used as a reference
group when comparing group differences. Benjamini-Hochberg
false discovery rate (FDR) was used to adjust results for multiple
comparisons [33]. FDR p-value ,0.05 was considered as
statistically significant. The association of EPA and DHA with
DI was tested using Spearman rank correlation and linear
regression model (age, gender and weight changes were included
in the model). The results from regression model need to be
discussed with reservation, since the distributions of the variables
were not normal. Kruskal-Wallis test was performed in order to
test differences in changes in DI between different EPA and DHA
quartiles.
Results
Clinical characteristics and dietary intake
There were no statistically significant differences between the
groups at baseline (Table 1). The results of the basic clinical and
biochemical parameters (apart from glucose and insulin) during
the intervention periods will be reported elsewhere. Body weight
remained constant during the study in all groups.
Self-reported compliance with the diets was good. The mean
test bread consumption during the intervention period was 7.7, 7.9
and 6.8 portions per day in the HealthyDiet, WGED and Control
groups, respectively. In the HealthyDiet group, the mean fish
consumption was 3.3 fish meals per week. Mostly used fish species
were salmon, rainbow trout, vendace and Baltic herring. The
mean bilberry consumption in the HealthyDiet group was 3.2
portions per day.
Figure 2. Changes in dietary intake during the 12-week intervention in the HealthyDiet (n=36), Whole grain enriched diet (WGED)
(n=34) and Control (n=35) groups. Bars represent mean of absolute changes 6 SD. Means without a common letter differ in mixed model
comparison, FDR p,0.05.
doi:10.1371/journal.pone.0022646.g002
Table 2. Glucose and insulin parameters at baseline and after the 12-week intervention.
1
HealthyDiet n=37 WGED
2 n=34
Control
n=35
0w k 1 2w k
FDR p
group
3
FDR p
time*
group
4 0w k 1 2w k
FDR p
group
3
FDR p
time*
group
4 0w k 1 2w k
FDR p
group
3
Fasting glucose
(mmol/L)
6.160.5 6.060.5 0.71 0.91 6.160.4 6.160.5 0.99 0.90 6.260.5 6.260.5 0.81
Glucose 2 h
(mmol/L)
6.761.7 6.060.5 0.027 0.53 6.661.6 6.161.9 0.058 0.68 6.961.9 6.762.2 0.81
Fasting insulin
(mU/L)
11.765.9 12.566.3 0.37 0.91 12.066.2 13.768.0 0.16 0.73 12.866.6 13.266.3 0.81
Insulin 2 h
(mU/L)
62.6648.2 61.3646.7 0.69 0.91 78.3665.6 65.9659.9 0.16 0.67 72.1654.2 72.3655.7 0.95
AUC
5 for glucose
(mmol/L)
2416130 1906121 0.027 0.49 2336128 2046137 0.16 0.53 2466136 2466137 0.84
AUC
4 for insulin
(mU/L)
678763279 750963772 0.64 0.91 765066004 752364740 0.57 0.68 776664173 751463861 0.89
HOMA-IR
6 3.261.8 3.461.9 0.43 0.91 3.361.7 3.762.3 0.16 0.73 3.662.0 3.761.9 0.89
IGI
7 143699
9 2126251
10 0.076 0.49 1606115
11 1696113
11 0.99 0.91 157697 149689 0.89
QUICKY
8 0.3360.02 0.3360.02 0.37 0.91 0.3360.02 0.3260.03 0.16 0.90 0.3260.02 0.3260.02 0.81
Disposition index 46.3630.4
9 67.8678.8
10 0.08 0.49 51.5635.2
11 53.7634.3
11 0.99 0.91 50.0628.2 47.6627.2 0.82
1Values are mean 6 SD,
2Whole grain enriched diet,
3False discovery rate p-value for effect of time within the groups,
4False discovery rate p-value for interaction of time and group (time*group),
5Area under the curve in 2-hour OGTT,
6Homeostasis model of insulin resistance,
7Insulinogenic index,
8Quantitative insulin sensitivity check index,
9n=36,
10n=35,
11n=32.
doi:10.1371/journal.pone.0022646.t002
Effects of Diet on Glucose and Lipid Metabolism
PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e22646At the baseline, the intake of dietary fiber was higher in the
HealthyDiet group than in the Control and WGED groups (FDR
p=0.013). Otherwise, dietary intake did not differ at baseline
among the groups. Energy intake did not change during the
intervention. The intake of EPA, DHA, a-linolenic acid and fiber
increased in the HealthyDiet group compared with the Control
group (Figure 2). In the WGED group, the intake of total fat
decreased and fiber increased compared with the Control group.
Within the Control group the intake of PUFA, EPA, DHA and
fiber decreased during the intervention.
Glucose and insulin metabolism
There were no statistical differences in changes of glucose and
insulin metabolism between the groups (Table 2). In the
HealthyDiet group, the within-the-group comparison revealed
decreases in the 2-hour glucose concentration and AUC for
glucose (Table 2, Figure 3). There was a trend towards
improved IGI (p=0.016 and FDR p=0.076) and DI (p=0.019
and FDR p=0.076) within the HealthyDiet group (Table 2,
Figure 3).
Fatty acids and lipidomics
There were no differences in plasma fatty acids between the
groups at baseline. Proportions of di-homo-c-linolenic acid
decreased and polyunsaturated long chain fatty acids (docosapen-
taenoic acid, EPA, DHA) increased in the HealthyDiet group
compared with the Controls (Table 3). Within the Control group,
DHA decreased during the intervention. There were no significant
changes in plasma fatty acid composition in the WGED group.
A total of 364 lipids were identified and quantified by the
UPLC-MS platform including lipid classes such as TGs, LPCs,
phophatidylcholines (PCs), phosphatidylserines (PSs), phosphatidyl
ethanolamines (PEs), sphingomyelins (SMs) and ceramides. There
were no significant differences among the groups at baseline.
Using the within-the-group comparisons, 152, 91 and 178 lipids
changed significantly (FDR p,0.05) in the HealthyDiet, WGED
and Control groups, respectively. Mixed model analysis revealed
25 significantly changed lipids when comparing the HealthyDiet
and the WGED groups to the Control group (Table 4). All the
significant changes occurred in the HealthyDiet group. Multiple
TGs with the long chain PUFAs, including TG(60:12), TG(60:13),
TG(58:11), TG(56:10), increased in the HealthyDiet group. Also
LPC(20:5), PC(36:5), PC(38:7e), PC(40:7e) and TG(55:7) in-
creased, while the PS(38:2) and LPC(20:3) decreased. LPC(22:6)
increased within the HealthyDiet group (FDR p=0.005), but in a
comparison of all three groups together this increase did not reach
the level of statistical significance (FDR p=0.088). Odd chain
TGs, except TG(55:7), or ceramides did not change during the
intervention.
Figure 3. Bar charts of glucose metabolism parameters in each group before and after the intervention. A) plasma 2 hour glucose, B)
area under the curve (AUC) for glucose, C) Insulinogenic index (IGI) and D) Disposition index (DI) in OGTT. Values are means 6 SEM, n=37, 34 and 35
in the HealthyDiet, Whole grain enriched diet (WGED) and Control groups, respectively, except for IGI and DI, n=36 before and n=35 after the
intervention in the HealthyDiet group, and n=32 before and after the intervention in the WGED group.
doi:10.1371/journal.pone.0022646.g003
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metabolism
Regression model revealed significant association between the
changes in plasma EPA and DHA with changes in IGI (R=0.366,
p=0.009 and R=0.379, p=0.006) and DI (R=0.366, p=0.009
and R=0.382, p=0.005, respectively). The inclusion of changes in
the fiber intake in the regression model did not alter associations.
There were also positive correlations between the changes in EPA
and DHA and changes in IGI (r=0.309, p=0.002 and r=0.413,
p,0.001, respectively) and DI (r=0.313, p=0.002 and r=0.341,
p=0.001, respectively). IGI and DI improved most in the highest
quartiles of changes in EPA and DHA during the 12-week
intervention (Figure 4).
Discussion
We studied the effects of whole grain and low insulin response
grain products, fatty fish, and bilberries on glucose metabolism,
plasma fatty acids and lipidomic profile in individuals with features
of the metabolic syndrome. We found that diet with high intake of
whole grain and low insulin response grain products, fatty fish and
bilberries (HealthyDiet) appeared to improve glucose metabolism
and altered plasma lipidomic profile markedly, while exclusive
carbohydrate modification caused only minor changes. Interest-
ingly, we identified an association between the increases in plasma
EPA and DHA contents and improvement in glucose metabolism.
A decreased AUC for glucose and a trend towards improved
IGI and DI in the HealthyDiet group suggest that the intake of
whole grain and low insulin response grain products, fatty fish and
bilberries had positive effects on insulin secretion and glucose
disposal in this study. There was also a trend towards improved 2-
hour glucose, but not for IGI and DI, in the WGED group. The
results for IGI and DI were very similar, which is not surprising as
DI is calculated from IGI. In the entire study group, a higher
increase in EPA and DHA was curvilinearly associated with IGI
and DI and thus to improved glucose metabolism. Besides fatty
fish, bilberries may also have had a role in the improved glucose
metabolism, but we do not have a biomarker for bilberry intake
which would have enabled better estimation of its effects.
However, not all subjects in the 4
th quartile of EPA and DHA
Table 4. Lipids that change significantly different between the groups after the 12-week intervention period.
1
Lipid
Beta HD
2 vs.
Control
FDR p HD
2 vs.
Control
3,4
Beta
HD
4
FDR p
HD
2,4,5
Beta
WGED
6
FDR p
WGED
4,5,6
Beta
Control
FDR p
Control
4,5
Beta HD
2 vs.
WGED
6
FDR p HD
2 vs.
WGED
6,7
TG(60:13) 0.35 0.007 0.35 7610
26 0.06 0.43 20.01 0.87 0.27 0.08
TG(60:12) 0.46 3610
24 0.42 3610
26 0.07 0.37 20.05 0.49 0.33 0.07
TG(60:12)
8 0.43 5610
24 0.41 5610
26 0.08 0.27 20.03 0.66 0.31 0.07
TG(58:11) 0.33 0.008 0.37 4610
26 0.08 0.33 0.04 0.50 0.27 0.08
TG(58:11)
8 0.29 0.013 0.34 4610
26 0.06 0.43 0.05 0.38 0.26 0.08
TG(58:10) 0.24 0.026 0.30 4610
26 0.05 0.42 0.06 0.29 0.23 0.08
TG(58:10)
8 0.22 0.041 0.31 4610
26 0.08 0.23 0.08 0.18 0.21 0.08
TG(56:10) 0.24 0.013 0.31 4610
26 0.07 0.31 0.05 0.26 0.22 0.08
TG(56:9) 0.22 0.041 0.31 4610
26 0.06 0.38 0.09 0.14 0.24 0.07
TG(56:6) 0.17 0.019 0.18 6610
26 0.04 0.44 20.001 0.97 0.13 0.12
TG(55:7) 0.27 0.036 0.29 7610
25 0.10 0.17 0.01 0.87 0.19 0.19
TG(54:8) 0.25 0.020 0.31 5610
26 0.08 0.24 0.05 0.40 0.21 0.08
PC(40:7e) 0.14 0.013 0.11 3610
24 0.04 0.31 20.03 0.25 0.06 0.35
PC(40:7e)
8 20.15 0.041 20.03 0.48 0.09 0.044 0.12 0.007 20.13 0.08
PC(40:4) 20.23 0.040 20.04 0.58 0.12 0.07 0.18 0.004 20.18 0.17
PC(38:7e) 0.13 0.013 0.11 2610
24 0.02 0.63 20.02 0.39 0.08 0.19
PC(38:7) 0.15 0.040 0.19 1610
25 0.08 0.08 0.03 0.49 0.10 0.22
PC(38:4e) 20.14 0.013 20.03 0.33 0.03 0.22 0.10 0.004 20.07 0.24
PC(36:5) 0.19 0.013 0.24 4610
26 0.07 0.13 0.04 0.41 0.16 0.08
PE(40:7) 20.13 0.040 20.08 0.032 0.04 0.24 0.06 0.10 20.12 0.08
PE(38:7e) 0.20 0.013 0.20 2610
25 0.08 0.09 20.01 0.87 0.11 0.22
PE(38:4)/
PC(35:4)
20.13 0.013 20.02 0.43 0.06 0.048 0.10 0.009 20.09 0.08
PS(38:2) 20.14 0.013 20.09 0.010 0.02 0.54 0.05 0.10 20.11 0.08
LPC(20:5) 0.21 0.007 0.15 0.002 20.001 0.97 20.05 0.17 0.16 0.08
1n=105,
2HealthyDiet group,
3False discovery rate p-value for interaction of time and group (time*group), the HealthyDiet group compared with the Controls,
4Age, gender, BMI, Insulin and glucose are used as covariates,
5False discovery rate p-value for effect of time within the groups,
6Whole grain enriched diet group,
7False discovery rate p-value for interaction of time and group, the HealthyDiet group compared with the WGED group,
8Lipids which are mentioned twice are isobaric, meaning that the fatty acid composition differs.
doi:10.1371/journal.pone.0022646.t004
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changes in the EPA and DHA may have an independent
association with the glucose metabolism. Recently, Stull and
colleagues [34] showed that insulin sensitivity was enhanced after
6 wk dietary supplementation with bioactive substances from
bilberries in 32 obese, insulin-resistant persons.
Results from the intervention studies regarding the effects of (n-
3) PUFA of animal origin on glucose metabolism (mostly insulin
resistance) have been variable and most of the studies have been
performed with fish oil supplements [18]. There are multiple
discrepancies between the (n-3) PUFA intervention studies relating
to e.g. methods they have used to assess glucose metabolism,
health status of participants, diet or duration of the study [18].
Improvements in insulin resistance have not been observed in
healthy individuals or diabetic persons, but the positive effects
have been identified in obese individuals [16,18,35]. Our study
population could have been an optimal target group for the
application of dietary strategy to improve glucose metabolism,
since the participants had IFG or IGT, but not diabetes. However,
the diet rich in whole grain and low insulin response grain
Figure 4. Associations between glucose metabolism and plasma EPA and DHA content. Changes in insulinogenic index (IGI) (A and B) and
disposition index (DI) (C and D) during the intervention period (95% Confidence interval) according to quartiles of changes in plasma EPA (A and C)
and DHA (B and D) content (%). * p,0.01 in Kruskal-Wallis test. All groups combined, n=99. Ranges of changes in EPA quartiles: 1=22.3–0.4% units;
2=20.320.1% units; 3=0.120.6% units; 4=0.624.2% units, and in DHA quartiles: 1=22.4–0.6% units; 2=20.6–0.1% units; 3=20.0420.7% units;
4=0.723.0% units.
doi:10.1371/journal.pone.0022646.g004
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but instead improved insulin secretion in this study. Associations
between the changes in plasma EPA and DHA content and
improved IGI and DI were curvilinear (Figure 4), meaning that
the improved insulin secretion and glucose disposal existed only in
the highest quartiles of changes in EPA and DHA. This may partly
explain the discrepancy on the evidence related to (n-3) PUFA of
animal origin and glucose metabolism. Future studies are needed
to confirm these results and to find the optimal amount of fish
needed to achieve improvement in insulin metabolism in subjects
with IFG or IGT.
High-carbohydrate-low-GI diet has been shown to improve DI
in persons with impaired glucose tolerance [2,36] or type 2
diabetes [37]. In two studies the duration of the low-GI diet has
been 4 to 12 months until the increase in DI has became evident
[36,37]. However, Laaksonen and colleagues detected improved
DI after 12-week consumption of carbohydrate modified diet with
cereal products replaced with rye-based products and whole-grain
pasta [2]. It is unlikely, but still possible, that our intervention
period of 12-weeks was too short to observe the improvement in
DI in the WGED group, while the effects of (n-3) PUFA appeared
earlier. In addition, the improvement in DI in the HealthyDiet
group might have reached the level of statistical significance after
the longer intervention period. Moreover, there were slight
differences in the cereal diets between WGED group and in the
study of Laaksonen et al [2] that might have had an impact on the
differences found.
Fatty acid analyses revealed increases in the plasma content of
long chain (n-3) PUFAs in the HealthyDiet group, whereas in the
Control group plasma content of DHA decreased without a
change in the WGED group. Furthermore, lipidomics analysis
revealed increases in TGs with long chain (n-3) PUFAs in the
HealthyDiet group. These changes confirm the good compliance
with the instructions of fish intake. Interestingly, we detected
increases in highly unsaturated TGs in the HealthyDiet group (e.g.
TG(60:12) and TG(60:13)), which we have not identified in our
previous studies.
We observed increased plasma concentrations of LPC species in
the HealthyDiet group. LPCs are linked with atherosclerosis by
virtue of their effects on arterial wall, smooth muscle cells and
macrophages, although also other putative antiatherogenic effects
have been demonstrated [38]. LPC is a major component of
oxidized LDL [38,39]. In high density lipoprotein (HDL) fraction,
it is more abundant in persons with high HDL cholesterol [40].
The acyl chains in LPC and lysophosphatidicacid (LPA) molecules
vary from saturated to highly unsaturated, and from 14 to 22
carbons, and their biological functions may vary depending on the
acyl chain [38,41,42]. Block and colleagues [42] demonstrated
that dietary EPA and DHA fatty acids are incorporated into
plasma LPCs, but not into LPAs. Here we found increase in
LPC(20:5) after a 12-week consumption of fatty fish. LPC(22:6)
also increased within the HealthyDiet group, but among the
groups this increase did not reach the level of statistical
significance. The ability to increase LPC(20:5) and LPC(22:6)
with dietary ingestion of fatty fish may be important, since LPC
are believed to be major carriers of DHA to the brain [43].
We found an increase of odd chain triglyceride TG(55:7) in the
HealthyDiet group. Other odd chain TG:s did not change. Odd
chain fatty acids 15:0 and 17:0 have been considered as a
biomarker of dairy fat intake, and thus even hypothesized to have
protective effects against heart disease, stroke and insulin
resistance [44–47]. These observations have been based on plasma
and adipose tissue levels of 15:0 and 17:0 rather than dietary
recording methods. Contradictory, association between the intake
of dairy fat and relative serum content of 17:0 have not been clear
in every study [48] and also inverse associations have been
observed [49]. Furthermore, in the large cohort study EPIC, there
was a strong positive correlation (r=0.8, p#0.01) between the
total intake of fish and plasma content of 17:0 [50]. In our study,
plasma 15:0 did not change during the intervention, and 17:0 was
used as an internal standard in the fatty acid analyses, so we could
not determine its plasma levels. However, TGs with the odd
number of carbons most likely include 15:0 and17:0 fatty acids.
Based on 4-day food diaries dietary intake of SAFA decreased
from 12 E% to 10.7 E% within the HealthyDiet group. This
indicates compliance to the instruction to avoid cream and butter
in fish preparation. Decreased dairy fat intake should also have
been shown in a decrease of odd chain fatty acids, if those could be
considered as good biomarkers for dairy fat intake. Fatty acid 17:0
is present in the fat of fish in low amounts (0.31–2.0% depending
on fish species) [51,52]. Salmon contains around 40 mg of 17:0
and 20 mg of 15:0 fatty acids per 100 g of fish [53]. Our results
suggest that intake of odd chain fatty acids from dairy fat
decreased, but instead the same amount of it came from fatty fish,
keeping the plasma concentration constant. Therefore, we believe
that it is questionable to consider odd chain fatty acids as
biomarkers of dairy fat intake and the associated health effects
might as well be related to high intake of fish. Further studies are
needed to address this issue.
In the WGED group, we did not find significant changes in
lipids in comparison with the Control group. This is consistent
with our earlier findings, i.e., the intake of low insulin response
grain products (rye bread and pasta) [12] or the intake of high-
fiber rye bread [54] did not lead to changes in serum lipidomic
profiles. Changes in the HealthyDiet group are different than
those which we found in our previous study, where the study
persons ate at least 4 fatty or lean fish meals per week [25]. In that
study, unlike in the present one, we found a decrease in plasma
ceramides and LPCs as a result of fatty fish diet. However,
participants in that study were coronary heart disease patients with
multiple medications, which may have affected the results. This
discrepancy also suggests that even if carbohydrate modification
itself does not markedly change serum lipidomic profile, it has
effects with bilberries and fatty fish, which cause changes in
lipidomic profile. On the other hand, it is possible that the intake
of three fish meals per week was not enough to see all the effects,
which were detectable after four fish meals per week. Furthermore,
the power calculations were based on fasting glucose, and it is
possible that there was not enough power to see all changes in
lipidomics or other glucose parameters. To see also the individual
effects of fish or bilberries, and also synergistic effects of grain
products, fish and bilberries, separate intervention groups with
increased intake of only fish or only bilberries would have been
needed.
In conclusion, our results suggest that diet rich in whole grain
and low insulin response grain products, bilberries, and fatty fish
alter plasma lipidomic profiles and may be associated with
improved glucose metabolism. Therefore, in long-term these
dietary components may have a beneficial role in the prevention of
type 2 diabetes in persons with impaired glucose metabolism.
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